Pharma-bio Serv's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Pharma-bio Serv in the third quarter 2026?
Pharma-Bio Serv, Inc. achieved a return on average equity (ROE) of 0.94 % in its third quarter 2026, which is below Pharma-bio Serv's average return on equity, which stands at 14.2%.

While the company's net income was fading, Pharma-bio Serv was able to improve its ROE compared to the second quarter 2026.

Within the Consulting Services industry Pharma-Bio Serv, Inc. achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 0 to 2727.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 31 2026) III. Quarter	(Apr 30 2026) II. Quarter	(Jan 31 2026) I. Quarter	(Oct 31 2025) IV. Quarter	(Jul 31 2025) III. Quarter
Y / Y Equity Change	-12.42 %	-13.77 %	-13.13 %	-13.13 %	-
Y / Y Net Income Change	-	51.65 %	287.06 %	-	-
Net Income (TTM) in Millions	0	0	0	0	0
Return On Equity (TTM)	0.94 %	-0.23 %	-0.64 %	-0.81 %	-0.65 %
PBSV's Total Ranking	# 2727	# 0	# 2625	#	#
Equity (TTM) in Millions	10	10	12	12	12
Seq. Equity Change	-0.09 %	-12.25 %	0 %	-0.1 %	-1.62 %
Seq. Net Income Change	-	339.74 %	-	-	-

Back to PBSV Management Effectiveness >> PBSV's 5 Years Annual ROE >> Compare PBSV ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	# 2727

Return On Equity Statistics
High	Average	Low
49.84 %	14.2 %	-17.71 %
(Jul 31 2012)		(Jul 31 2024)

PBSV Annual Return On Equity	(Oct 31 2025) 2025	(Oct 31 2024) 2024	(Oct 31 2023) 2023	(Oct 31 2022) 2022	(Oct 31 2020) 2020
Total Equity in Millions	12	14	16	17	23
Y / Y Equity Change	-13.13 %	-14.95 %	-2.6 %	-27.11 %	10.24 %
Net Income in Millions	0	1	-1	1	2
Y / Y Net Income Change	-	-	-	-50.91 %	-1.74 %
Return On Equity	-0.84 %	5.67 %	-8.12 %	6.08 %	9.03 %

Back to PBSV Management Effectiveness >> PBSV's 5 Years Annual ROE >> Compare PBSV ROE to its Competitors

More Return On Equity Ratios
Consulting Services Industry Roe Trends and Statistics
Services Sector Return On Equity Statistics
PBSV's' Return on Equity at Yahoo Finance
PBSV's Roe Ratio versus Consulting Services Industry, Services Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PBSV's Competitors
Subscribers only: Roe for Pharma-bio Serv's Suppliers
Subscribers only: Return On Equity for PBSV's Customers

Companies with similar Return On Equity at Jul 31 2026, within Services Sector	ROE
Herc Holdings Inc	2.56 %
Stagwell Inc	2.48 %
Avalon Holdings Corporation	2.44 %
Marcus and Millichap Inc	2.44 %
Paid Inc	2.34 %
Mastech Digital Inc	2.31 %
Hyatt Hotels Corporation	2.21 %
Reservoir Media inc	2.13 %
Star Holdings	1.48 %
Tejon Ranch Co	1.23 %
American Realty Investors Inc	1.22 %
Nuvera Communications Inc	1.20 %
Zillow Group Inc	1.18 %
Pharma-Bio Serv, Inc.	0.94 %
Costar Group Inc	0.90 %
Dhi Group Inc	0.86 %
Casella Waste Systems Inc	0.36 %

Date modified: 2026-09-15T11:59:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.